In recent years, hundreds of clinical studies on psychedelics have been launched around the world. Countries such as Germany and the Czech Republic have also legally authorized, for example, psilocybin-assisted therapy for the treatment of depression through legislation. Is the growing interest in psychedelic therapies part of a growing hype bubble, or is the psychedelic renaissance truly taking hold in Finland as well? Come learn more and network around this topic!

About the speaker:

Aleksi Hupli received his Ph.D. in social sciences from the University of Tampere in 2021. Hupli’s dissertation research focused on the beneficial use of cognitive-enhancing substances among students , microdosing of psychedelics, and medical cannabis. His nonfiction book based on his dissertation (“Intelligence from Medicines and Substances? The Beneficial Use of Consciousness-Altering Substances,” Siltala 2024) won the “Science Book of the Year 2024” award from the Finnish Association of Science Publishers. Hupli’s latest non-fiction book is titled *Psychonaut: A Psychedelic A Conceptual Guide to the Mind’s Manifesto (Siltala 2026), in which he explores the psychedelic renaissance. Hupli helped coordinate one of Finland’s clinical research centers in a multicenter study that investigated psilocybin-assisted therapy for the treatment of alcoholism. In addition, he is a member of the European psychedelic research network (Psychedelic Renaissance: Turn On, Tune In, and Drop In, PSY-NET), a deputy board member of the Psychedelic Research Association, and a Association for Humane Substance Abuse Policy.